Feldman E - Search Results

1

Homoharringtonine is safe and effective for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Leukemia. 1992 Nov;6(11):1185-8. Leukemia. 1992. PMID: 1434802 Clinical Trial.

2

Long-term follow-up of high-dose mitoxantrone-based induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Twelve year results from a single institution.

Seiter K, Liu D, Feldman E, Shi Q, Qureshi A, Arshad M, Walia T, Naseer N, Baskind P, Ahmed T. Seiter K, et al. Among authors: feldman e. Leuk Lymphoma. 2006 Mar;47(3):425-32. doi: 10.1080/10428190500331600. Leuk Lymphoma. 2006. PMID: 16396765 Clinical Trial.

3

"Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment.

Arlin ZA, Feldman EJ, Finger L, Ahmed T, Mittelman A, Puccio C, Cook P, Chun HG. Arlin ZA, et al. Among authors: feldman ej. Semin Hematol. 1991 Jul;28(3 Suppl 4):44-7. Semin Hematol. 1991. PMID: 1780752 Review. No abstract available.

4

Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia.

Arlin ZA, Feldman EJ, Mittelman A, Ahmed T, Puccio C, Chun HG, Cook P, Baskind P, Marboe C, Mehta R. Arlin ZA, et al. Among authors: feldman ej. Cancer. 1991 Sep 15;68(6):1198-200. doi: 10.1002/1097-0142(19910915)68:6<1198::aid-cncr2820680603>3.0.co;2-e. Cancer. 1991. PMID: 1873770

5

Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia.

Arlin ZA, Feldman EJ, Finger LR, Ahmed T, Mittelman A, Cook P, Puccio C, Baskind P, Arnold P, Razis ED, et al. Arlin ZA, et al. Among authors: feldman ej. Leukemia. 1991 Aug;5(8):712-4. Leukemia. 1991. PMID: 1886423

6

Amsacrine is safe in patients with ventricular ectopy.

Puccio CA, Feldman EJ, Arlin ZA. Puccio CA, et al. Among authors: feldman ej. Am J Hematol. 1988 Jul;28(3):197-8. doi: 10.1002/ajh.2830280315. Am J Hematol. 1988. PMID: 2457309

7

Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph1-negative ALL.

Arlin ZA, Feldman EJ, Ahmed T, Liebowitz D, Shapiro LR, Wilmot PL. Arlin ZA, et al. Among authors: feldman ej. Acta Haematol. 1989;81(4):217-8. doi: 10.1159/000205565. Acta Haematol. 1989. PMID: 2502896 Free article.

8

Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhage.

Feldman EJ, Arlin ZA, Ahmed T, Mittelman A, Ascensao JL, Puccio CA, Coombe N, Baskind P. Feldman EJ, et al. Acta Haematol. 1989;82(3):117-21. doi: 10.1159/000205321. Acta Haematol. 1989. PMID: 2510432

9

Can we increase the cure rate of adults with acute lymphoblastic leukemia?

Arlin ZA, Feldman EJ. Arlin ZA, et al. Among authors: feldman ej. Leukemia. 1989 Apr;3(4):318-20. Leukemia. 1989. PMID: 2927182 No abstract available.

10

Modern management of chronic myelogenous leukemia (CML).

Feldman EJ, Arlin ZA. Feldman EJ, et al. Cancer Invest. 1988;6(6):737-42. doi: 10.3109/07357908809078041. Cancer Invest. 1988. PMID: 3072996 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,426 results

Search Page

Filters